| Serial Number | 98592556 |
| Word Mark | OPERA |
| Filing Date | Monday, June 10, 2024 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Thursday, July 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Custom manufacture of pharmaceuticals, namely, oligonucleotides and RNAs for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders |
| Goods and Services | Oligonucleotide compounds being a component in pharmaceutical preparations for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; RNA compounds being a component in pharmaceutical preparations for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; RNA therapeutic agents for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Nucleic acid therapeutic agents for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Oligonucleotide compounds being a component in pharmaceutical preparations for use in RNA editing for treating genetic diseases; Oligonucleotide compounds being a component in pharmaceutical preparations for use in base editing for treating genetic diseases; Oligonucleotide compounds being a component in pharmaceutical preparations for use as RNA therapeutic for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Oligonucleotide compounds being a component in pharmaceutical preparations for treating genetic diseases that facilitate the editing of RNA base; Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutic agents for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; pharmaceuticals, namely, bio-pharmaceutical preparations for the treatment of rare diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 10, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 10, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Korro Bio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02141 |
| Event Date | Event Description |
| Saturday, December 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, June 10, 2024 | NEW APPLICATION ENTERED |
| Thursday, April 3, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, December 17, 2024 | ASSIGNED TO EXAMINER |
| Thursday, April 3, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, April 3, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 22, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 22, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 22, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 23, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 24, 2025 | LETTER OF SUSPENSION E-MAILED |
| Thursday, July 24, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, July 24, 2025 | SUSPENSION LETTER WRITTEN |
| Tuesday, April 22, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 22, 2025 | NON-FINAL ACTION WRITTEN |